Evidence map›Paper›PMID 28892415›Full record

ArticleVirulence2017

Susceptibility of Mycobacterium tuberculosis-infected host cells to phospho-MLKL driven necroptosis is dependent on cell type and presence of TNFα.

Rachel E Butler, Nitya Krishnan, Waldo Garcia-Jimenez, Robert Francis, Abbe Martyn, Tom Mendum, Shaza Felemban, Nicolas Locker, Francisco J Salguero, Brian Robertson and 1 more

Open access · goldAbstract read
In one paragraph

Article in Virulence, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Necrosis drives susceptibility toInfection and immunity · 2025
    Article
  2. Article
  3. Necrosis drives susceptibility tobioRxiv : the preprint server for biology · 2024
    Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. NADCell reports · 2018
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Rachel E Butlera Department of Microbial and Cellular Sciences , Faculty of Health and Medical Sciences, University of Surrey , Guildford , Surrey , UK.
Nitya Krishnanb MRC Centre for Molecular Bacteriology and Infection , Department of Medicine, Flowers Building, Imperial College London , South Kensington , London , UK.
Waldo Garcia-Jimenezc Department of Pathology and Infectious Diseases, School of Veterinary Medicine, University of Surrey , Guildford , Surrey , UK.
Robert Francisa Department of Microbial and Cellular Sciences , Faculty of Health and Medical Sciences, University of Surrey , Guildford , Surrey , UK.
Abbe Martync Department of Pathology and Infectious Diseases, School of Veterinary Medicine, University of Surrey , Guildford , Surrey , UK.
Tom Menduma Department of Microbial and Cellular Sciences , Faculty of Health and Medical Sciences, University of Surrey , Guildford , Surrey , UK.
Shaza Felembana Department of Microbial and Cellular Sciences , Faculty of Health and Medical Sciences, University of Surrey , Guildford , Surrey , UK.
Nicolas Lockera Department of Microbial and Cellular Sciences , Faculty of Health and Medical Sciences, University of Surrey , Guildford , Surrey , UK.
Francisco J Salgueroc Department of Pathology and Infectious Diseases, School of Veterinary Medicine, University of Surrey , Guildford , Surrey , UK.
Brian Robertsonb MRC Centre for Molecular Bacteriology and Infection , Department of Medicine, Flowers Building, Imperial College London , South Kensington , London , UK.
Graham R Stewarta Department of Microbial and Cellular Sciences , Faculty of Health and Medical Sciences, University of Surrey , Guildford , Surrey , UK.
University of Surrey · GBImperial College London · GB

Funding

Medical Research Council MR/P028225/1Wellcome Trust WT090242MA
6 · The paper itself

Abstract

An important feature of Mycobacterium tuberculosis pathogenesis is the ability to control cell death in infected host cells, including inhibition of apoptosis and stimulation of necrosis. Recently an alternative form of programmed cell death, necroptosis, has been described where necrotic cell death is induced by apoptotic stimuli under conditions where apoptotic execution is inhibited. We show for the first time that M. tuberculosis and TNFα synergise to induce necroptosis in murine fibroblasts via RIPK1-dependent mechanisms and characterized by phosphorylation of Ser345 of the MLKL necroptosis death effector. However, in murine macrophages M. tuberculosis and TNFα induce non-necroptotic cell death that is RIPK1-dependent but independent of MLKL phosphorylation. Instead, M. tuberculosis-infected macrophages undergo RIPK3-dependent cell death which occurs both in the presence and absence of TNFα and involves the production of mitochondrial ROS. Immunocytochemical staining for MLKL phosphorylation further demonstrated the occurrence of necroptosis in vivo in murine M. tuberculosis granulomas. Phosphorylated-MLKL immunoreactivity was observed associated with the cytoplasm and nucleus of fusiform cells in M. tuberculosis lesions but not in proximal macrophages. Thus whereas pMLKL-driven necroptosis does not appear to be a feature of M. tuberculosis-infected macrophage cell death, it may contribute to TNFα-induced cytotoxicity of the lung stroma and therefore contribute to necrotic cavitation and bacterial dissemination.

Indexed as

ApoptosisAnimalsFemaleHumansMacrophagesMiceMice, Inbred BALB CMycobacterium tuberculosisNecrosisPhosphorylationProtein KinasesSpecies SpecificityTuberculosisTumor Necrosis Factor-alphaMLKL protein, mouseProtein KinasesTumor Necrosis Factor-alphafibroblastmacrophageMLKLMycobacterium tuberculosisnecroptosisRIPK1RIPK3

Identifiers

PMID28892415
PMCPMC5750806
OpenAlexW2754070890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.